Draft Policy Recognizes the Importance of Surveillance Testing for Early Detection of Allograft Rejection in Kidney, Heart, and Lung BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (CDNA) – The ...
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback